The company reached a deal to divest its third biosimilar this year, selling a copycat version of Amgen’s Neulasta for up to ...

While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to ...

BALTIMORE, MD, December 3, 2024 — Sapio Sciences, the science-awareTM lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic ...